Chris Degnan
Director of Finance/CFO bei GALERA THERAPEUTICS, INC.
Vermögen: 1 400 $ am 31.03.2024
Profil
Chris Degnan is currently the Chief Financial & Accounting Officer at Galera Therapeutics, Inc. He previously worked as a Senior Finance Director at AstraZeneca PLC from 2004 to 2014.
From 2014 to 2018, he served as the Chief Financial Officer at Endo International Plc.
He also held the position of Chief Financial Officer & Vice President-Finance at Endo Pharmaceuticals, Inc. Additionally, he worked as the Chief Financial & Accounting Officer at Verrica Pharmaceuticals, Inc. from 2018 to 2019.
Mr. Degnan completed his undergraduate degree at the University of Notre Dame.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.04.2023 | 10 000 ( 0,02% ) | 1 400 $ | 31.03.2024 |
Aktive Positionen von Chris Degnan
| Unternehmen | Position | Beginn |
|---|---|---|
| GALERA THERAPEUTICS, INC. | Director of Finance/CFO | 21.10.2019 |
Ehemalige bekannte Positionen von Chris Degnan
| Unternehmen | Position | Ende |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Director of Finance/CFO | 07.10.2019 |
| ENDO INTERNATIONAL PLC | Director of Finance/CFO | 01.03.2018 |
| ASTRAZENECA PLC | Director of Finance/CFO | 01.11.2014 |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Director of Finance/CFO | - |
Ausbildung von Chris Degnan
| University of Notre Dame | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| GALERA THERAPEUTICS, INC. | Health Technology |
| ENDO INTERNATIONAL PLC | Health Technology |
| VERRICA PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
